Tom Taulli

Tom Taulli

InvestorPlace Contributor

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Facebook Inc (FB) Stock: Is Messenger Even Bigger Than Social Media?

By Tom Taulli, InvestorPlace Contributor

Social media has been huge for Facebook stock, but going forward, messaging may be even bigger. The good news is that FB is a dominant player in the space, with assets like Facebook Messenger and WhatsApp.

Pandora Media Inc: Pandora Stock Still out of Tune (P)

By Tom Taulli, InvestorPlace Contributor

Whispers of a Pandora stock buyout may prove to be nothing more than rumors now that founder Tim Westergren is back as CEO.

GameStop Corp.: GME May Face the Hunger Games

By Tom Taulli, InvestorPlace Contributor

Gamestop is facing a tough change in its business, as consumers increasingly use the Internet to download games, and GME's diversification tactics may not be enough.

The iPhone SE Fills a Big Need for Apple Inc. (AAPL)

By Tom Taulli, InvestorPlace Contributor

Apple might be shooting low with the iPhone SE, but AAPL still can squeeze some growth juice from its cheapest smartphone ever.

Eli Lilly and Co: Can LLY Stock Get Healthy Again?

By Tom Taulli, InvestorPlace Contributor

Eli Lilly has been awful for investors this year, but LLY does have a robust pipeline that is focused on major diseases.

Load More